☆ 4.4 Letter

Mechanism of impaired glucose metabolism during nilotinib therapy in patients with chronic myelogenous leukemia

HAEMATOLOGICA (2013)

Journal

HAEMATOLOGICA

Volume 98, Issue 10, Pages -

Publisher

FERRATA STORTI FOUNDATION

DOI: 10.3324/haematol.2013.086355

Keywords

nilotinib; tyrosin kinase inhibitor; glucose metabolism

Categories

Hematology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.